Antineoplastic Agents - Lp Containing Lonkastuximab Tesirin 2025. The Subject Of The Public Contract Is Recurring Supplies Of Medicinal Products Containing The Active Substance Lonkastuximab Tesirin.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.